Sarcopenia-related parameters and incident disability in older persons: Results from the "Invecchiare in Chianti" study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 70, Issue 4, 2015, Pages 457-463

  Cesari, Matteo ^a   Rolland, Yves ^a   Van Kan, Gabor Abellan ^a   Bandinelli, Stefania ^b   Vellas, Bruno ^a   Ferrucci, Luigi ^c  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Body composition; Disability; Gait speed; Sarcopenia; Skeletal muscle

Indexed keywords

AGED; AGING; BODY MASS; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DISABLED PERSON; FEMALE; FOLLOW UP; GAIT; GERIATRIC ASSESSMENT; HAND STRENGTH; HUMAN; INCIDENCE; ITALY; MALE; METHODOLOGY; MUSCLE STRENGTH; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PREVALENCE; PROCEDURES; RISK FACTOR; SARCOPENIA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX RATIO; STATISTICS AND NUMERICAL DATA;

ACTIVITIES OF DAILY LIVING; AGED; AGING; BODY MASS INDEX; DISABLED PERSONS; FEMALE; FOLLOW-UP STUDIES; GAIT; GERIATRIC ASSESSMENT; HAND STRENGTH; HUMANS; INCIDENCE; ITALY; MALE; MUSCLE STRENGTH; PREDICTIVE VALUE OF TESTS; PREVALENCE; RESEARCH DESIGN; RISK FACTORS; SARCOPENIA; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 84926663867     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glu181     Document Type: Article

References (30)

1. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13:708-712.
2. Baumgartner RN, Koehler KM, Gallagher D, et al.et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-763.
3. Newman AB, Kupelian V, Visser M, et al.et al.; Health ABC Study Investigators. Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc. 2003;51:1602-1609. doi:10.1046/j.1532-5415.2003.51534.x
4. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al.et al.; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412-423. doi:10.1093/ageing/afq034
5. Muscaritoli M, Anker SD, Argilés J, et al.et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29:154-159. doi:10.1016/j.clnu.2009
6. Fielding RA, Vellas B, Evans WJ, et al.et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12:249-256. doi:10.1016/j.jamda.2011.01.003.
7. Morley JE, Abbatecola AM, Argiles JM, et al.et al.; Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12:403-409. doi:10.1016/j.jamda.2011.04.014
8. Studenski SA, Peters KW, Alley DE, et al.et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547-558. doi:10.1093/gerona/glu010
9. Cawthon PM, Peters KW, Shardell MD, et al.et al. Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:567-575. doi:10.1093/gerona/glu023
10. Dam TT, Peters KW, Fragala M, et al.et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol A Biol Sci Med Sci. 2014;69:584-590. doi:10.1093/gerona/glu013
11. McLean RR, Shardell MD, Alley DE, et al.et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci. 2014;69:576-583. doi:10.1093/gerona/glu012
12. Alley DE, Shardell MD, Peters KW, et al.et al. Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol A Biol Sci Med Sci. 2014;69:559-566. doi:10.1093/gerona/glu011
13. Cesari M, Vellas B. Sarcopenia: a novel clinical condition or still a matter for research? J Am Med Dir Assoc. 2012;13:766-767. doi:10.1016/j.jamda.2012.07.020
14. Ferrucci L, Bandinelli S, Benvenuti E, et al.et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc. 2000;48:1618-1625.
15. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
16. Rittweger J, Beller G, Ehrig J, et al.et al. Bone-muscle strength indices for the human lower leg. Bone. 2000;27:319-326. doi:10.1016/S8756-3282(00)00327-6
17. Goodpaster BH, Carlson CL, Visser M, et al.et al. Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol (1985). 2001;90:2157-2165.
18. Cesari M, Penninx BW, Lauretani F, et al.et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:249-254. doi:10.1093/gerona/59.3.M249
19. Barbat-Artigas S, Rolland Y, Cesari M, Abellan van Kan G, Vellas B, Aubertin-Leheudre M. Clinical relevance of different muscle strength indexes and functional impairment in women aged 75 years and older. J Gerontol A Biol Sci Med Sci. 2013;68:811-819. doi:10.1093/gerona/gls254
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198. doi:10.1016/0022-3956(75)90026-6
21. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401. doi:10.1177/014662167700100306
22. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-186. doi:10.1093/geront/9.3-Part-1.179
23. Patel KV, Coppin AK, Manini TM, et al.et al. Midlife physical activity and mobility in older age: the InCHIANTI study. Am J Prev Med. 2006;31:217-224.doi:10.1016/j.amepre.2006.05.005
24. Guralnik JM, Fried LP, Simonsick EM, Kasper JD, Lafferty ME. The Women's Health and Aging Study - Health and Social Characteristics of Older Women with Disability (NIH Pub No. 95-4009). Bethesda, MD: National Institute on Aging; 1995.
25. Efron B. The efficiency of Cox's likelihood function for censored data. J Am Stat Assoc. 1977;72:557-565.
26. Delmonico MJ, Harris TB, Lee JS, et al.et al.; Health, Aging and Body Composition Study. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769-774. doi:10.1111/j.1532-5415.2007.01140.x
27. Cesari M. Role of gait speed in the assessment of older patients. JAMA. 2011;305:93-94. doi:10.1001/jama.2010.1970
28. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385-397. doi:10.1007/s00198-007-0543-5
29. Cesari M, Fielding RA, Pahor M, et al.et al. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Frailty Aging. 2012;1:102-110.
30. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging. 2009;13:724-728. doi:10.1007/s12603-009-0204-9